期刊文献+

营养支持治疗对儿童神经母细胞瘤临床疗效的影响 被引量:1

Effect of nutritional support therapy on the clinical efficacy of neuroblastoma in children
在线阅读 下载PDF
导出
摘要 目的:评估营养支持治疗对神经母细胞瘤(nueroblastoma,NB)患儿临床疗效的影响。方法:纳入2014年10月至2016年12月期间在我院初诊为NB的患儿106例,分为规范营养支持治疗组(A组)52例和非规范营养支持治疗组(B组)54例,评估2组患儿初诊时营养状况,分析2组患儿在手术后、化疗后其营养学指标变化、肿瘤治疗期间并发症发生率、卫生经济学指标。结果:(1)初诊时、术后及化疗后A组患儿中上臂围分别为(8.2±2.6)、(9.5±2.2)、(9.8±2.0)cm,B组患儿分别为(7.0±2.3)、(6.5±1.4)、(6.5±1.2)cm,A组患儿三角肌皮褶厚度分别为(4.8±1.2)、(6.2±1.6)、(6.4±1.5)mm,B组患儿分别为(3.9±3.4)、(4.5±1.2)、(4.6±1.1)mm,2组间比较有统计学意义(P<0.05),A组各时间点之间比较有统计学意义(P<0.05),而B组无统计学意义(P>0.05)。(2)术后A组出现伤口裂开及感染发生率为1.9%,B组为18.5%,2组间比较有统计学意义(P<0.05)。(3)在化疗4疗程后,A组骨髓抑制、胃肠道症状以及呼吸道感染发生率明显低于B组(P<0.05)。(4)A组平均住院时间、平均住院次数、平均住院费用、非计划再入院率也明显低于B组(P<0.05)。结论:NB患儿经规范营养支持治疗后,可有效改善营养状况,降低手术、化疗带来的并发症,提高患儿对NB治疗耐受性。 Objective:To evaluate the effect of nutritional support therapy on the clinical efficacy of nueroblastoma(NB). Methods:A total of 106 children with NB admitted from October 2014 to December 2016 were enrolled and divided into the nutrition treatment group(group A,52 cases)and non-nutritional treatment group(group B,54 cases). The nutritional status of the two groups at the initial diagnosis was evaluated,and the nutritional indicators,the incidence of complications and the health economics index of the two groups after operation and chemotherapy were analyzed respectively. Results:(1)The middle upper arm circumferences of the children in group A at the initial diagnosis,after operation and after chemotherapy were(8.2±2.6),(9.5±2.2),and(9.8±2.0)cm respectively,while those in group B were(7.0±2.3),(6.5±1.4),(6.5±1.2)cm respectively. The deltoid skin fold thicknesses of the children in group A were(4.8±1.2),(6.2±1.6),(6.4±1.5)mm respectively,while those in group B were(3.9±3.4),(4.5±1.2),(4.6±1.1)mm respectively. The difference between the two groups was significant(P<0.05),and the differences among each two of the three time points in group A were also significant(P<0.05),while which in group B were not significant(P>0.05).(2)Postoperative wound dehiscence and infection complications in children were 1.9% in group A and 18.5% in group B,and the difference between the two groups was significant(P <0.05).(3)After 4 courses of chemotherapy,the incidences of myelosuppression,gastroin testinal symptoms and respiratory tract infection in group A were significantly lower than those in group B(P<0.05).(4)The average hospitalization duration,times,and cost,and the unplanned readmission rate in group A were also significantly lower than those in group B(P<0.05). Conclusion:The standardized nutrition support treatment for NB children can effectively improve the nutritional status,reduce the incidence of complications caused by surgery and chemotherapy,and improve the tolerance of children to tumor treatment.
作者 杨燕 杨娇 吕麟亚 孔粼 李长春 孔祥如 杨超 龚丽子 Yang Yah;Yang Jiao;Lu Linya;Kong Lin;Li Changchun;Kong Xiangru;Yang Chao;Gong Lizi(Department of Oncological Surgery,Children's Hospital of Chongqing Medical University, Key Laboratory of Ministry of Education for Child Development and Disorders,National and International Science and Technology Cooperation Base of the Critical Disorders in Child Development ,Key Laboratory of Chongqing City for Pediatrics)
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2019年第2期198-203,共6页 Journal of Chongqing Medical University
基金 重庆市卫生局重点资助项目(编号:2015ZDXM017)
关键词 儿童 神经母细胞瘤 营养不良 children neuroblastoma malnutrition
  • 相关文献

参考文献3

二级参考文献34

  • 1陈伟,蒋朱明,张永梅,王秀荣,陈春明,史轶蘩.欧洲营养不良风险调查方法在中国住院患者的临床可行性研究[J].中国临床营养杂志,2005,13(3):137-141. 被引量:216
  • 2梁晓坤,揭彬,蒋朱明.营养风险理念解读[J].中国临床营养杂志,2007,15(3):167-170. 被引量:59
  • 3Howlader N, Noone AM, Krapcho M, et al, eds. SEER statistics review, 1975-2009 ( Vintage 2009 Populations)[M]. Bethesda, Md: National Cancer Institute, 2012.
  • 4Homer M J, Ries LA, Krapcho M, et al. SEER cancer statistics review, 1975-2006[M]. Bethesda, Md: National Cancer Institute, 2009.
  • 5Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, andresponse to treatment[J]. J Clin Oncol, 1993, 11 (8): 1466- 1477.
  • 6Shimada H,Ambros IM, Dehner LP, et al. The Ivtemational Neuroblastoma Pathology Classification (the Shimada system) [J]. Cancer,1999,86 (2) : 364-372.
  • 7Peuchmaur M Amore ES, Joshi VV, et al. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular [J ]. Cancer, 2003, 98 (10) : 2274-2281.
  • 8Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report [J]. J Clin Oncol , 2009, 27 (2): 298-303.
  • 9Brisse HJ,McCarville MB, Granata C, et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project[D]. Radiology, 2011, 261 (1) : 243-257.
  • 10Brodeur GM,Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment[J]. J Clin Oncol, 1993,11 (8) : 1466- 1477.

共引文献142

同被引文献21

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部